electroCore (ECOR) has received two patent issue notifications from the United States Patent and Trademark Office. US Patent No. 12,208,263 entitled “Devices and Methods for Vagal Nerve Stimulation” was issued on January 28, 2025 and generally relates to methods for modulating the vagus nerve by positioning an electrode in contact with an electrically conductive gel on the neck of the user, delivering an electrical impulse to the vagus nerve and adjusting a position of the electrode on the neck based on a pressure sensation of the electrode against the neck. US Patent No. 12,213,795 entitled “Devices and Methods for Remote Therapy and Patient Monitoring” was issued on February 4, 2025 and generally relates to systems and methods for modulating a nerve within a user that include storing data related to parameters of an electrical impulse applied to the nerve, collecting user status data from the patient and comparing the user status data with the parameters of the electrical impulse. The user status data may include, for example, the severity of a headache.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ECOR:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue